HIGHLIGHTS
- who: Jianglei Li and collaborators from the Department of Gastroenterology, The Second Xiangya Hospital of Central South University, Changsha, China, Research Center have published the Article: Role of Selective Histone Deacetylase 6 Inhibitor ACY-1215 in Cancer and Other Human Diseases, in the Journal: (JOURNAL) of March/17,/2014
SUMMARY
To develop potentially less toxic and more effective treatments, studies on selective HDACs inhibitors are gradually deepening (Zhao et_al, 2021; He et_al, 2020). A series of compounds containing urea-based branched linkers with hydroxamate as ZBG have been identified as selective HDAC6 inhibitors . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.